SCHEMBL8286472

SCHEMBL8286472

O=C(Nc1ccccc1)c1cc2c(cn1)c(=O)cc(Nc1ccccc1)n2-c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 2/20 0.46
LCK P06239 1/20 0.46
KDM4E B2RXH2 2/20 0.43
NPC1 O15118 1/20 0.43
ALDH1A1 P00352 1/20 0.43
RAB9A P51151 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.39
P4HTM Q9NXG6 1/20 0.39
POLB P06746 1/20 0.38
KDR P35968 4/20 0.38
HMOX1 P09601 1/20 0.38
HMOX2 P30519 1/20 0.38
CNR1 P21554 1/20 0.38
TOP2A P11388 1/20 0.37
NR3C1 P04150 1/20 0.37
KMT2A Q03164 1/20 0.36
MAPT P10636 1/20 0.36
MAPK1 P28482 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
KMO O15229 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8287593 0.90 GSK3B (0.37) EGFRLCKNPC1ALDH1A1RAB9A
SCHEMBL8287205 0.89 GSK3B (0.37) EGFRLCK
SCHEMBL8286468 0.88 GSK3B (0.38) EGFRKDM4ENPC1ALDH1A1RAB9A
SCHEMBL8287936 0.87 RIPK1 (0.40) EGFRLCKPOLBNPSR1
SCHEMBL8287526 0.87 MAPK13 (0.38) EGFRKDM4ENPC1RAB9ASMN1; SMN2
SCHEMBL8287968 0.86 RIPK1 (0.41) EGFRNPC1RAB9AMAPT
SCHEMBL8362924 0.85 GSK3B (0.39) EGFRALDH1A1RAB9AKMT2AMAPT
SCHEMBL8287920 0.85 CSF1R (0.37) EGFRKDM4ENPC1RAB9ASMN1; SMN2
SCHEMBL8285291 0.84 GABRA1 (0.40) EGFRKDM4ENPC1ALDH1A1RAB9A
SCHEMBL5871843 0.82 MAT2A (0.40) KDM4EALDH1A1SMN1; SMN2KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed